Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

Figure 2

Pharmacokinetic linearity plots. (A) AUC vs. Dose and (B) Cmax vs. Dose. Diamonds represent Day 1, triangles represent Day 15. Solid line represents linear regression of Day 1 and Day 15 data combined. Dotted line is Day 1 only. Dashed and dotted line is Day 15 only. For Days 1 and 15 combined, coefficients of determination for AUC and Cmax were 0.7547 and 0.7637, respectively.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us